
BiotechTV - News Barclays Miami: Arvinas will have an update next week for its LRRK2 targeting PROTAC for Parkinson's. The new CEO previews that and talks other targets they are working on
Mar 10, 2026
Chapters
Transcript
Episode notes

BiotechTV - News